NF-κB and matrix-dependent regulation of osteopontin promoter activity in allylamine-activated vascular smooth muscle cells

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2012, Pages

  Williams, E Spencer ^a   Wilson, Emily ^b   Ramos, Kenneth S ^c  

^a TEXAS A AND M UNIVERSITY   (United States)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^c University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLYL AMINE; B FUNCTIONS; CELL SURFACES; DNA BINDING; DNA BINDING ACTIVITY; DNA BINDING SEQUENCE; EXTRACELLULAR MATRICES; IN-VIVO; INTEGRINS; MITOGENIC; OSTEOPONTIN; OVER-EXPRESSION; OXIDATIVE INJURY; PROMOTER ACTIVITIES; PROTEIN EXPRESSIONS; REGULATORY REGIONS; REPEATED CYCLE; SMOOTH MUSCLE CELLS; VASCULAR SMOOTH MUSCLE CELLS;

CELL CULTURE; HEALTH CARE; MEDICINE;

CELL MEMBRANES;

ALLYLAMINE; FIBRONECTIN; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OSTEOPONTIN; TRANSCRIPTION FACTOR REL; DNA;

5' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; DNA BINDING; DNA SEQUENCE; ENZYME SUBSTRATE; EXTRACELLULAR MATRIX; GEL MOBILITY SHIFT ASSAY; IMMUNOPRECIPITATION; INHIBITION KINETICS; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PHENOTYPE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; RAT; REGULATORY MECHANISM; RNA PURIFICATION; SITE DIRECTED MUTAGENESIS; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; ANIMAL; CELL CULTURE; CELL GROWTH; CYTOLOGY; DRUG EFFECT; GENETIC TRANSFECTION; GENETICS; METABOLISM; MOUSE; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

RATTUS;

ALLYLAMINE; ANIMALS; CELL GROWTH PROCESSES; CELLS, CULTURED; DNA; MALE; MICE; MUSCLE, SMOOTH, VASCULAR; MUTAGENESIS, SITE-DIRECTED; NF-KAPPA B; OSTEOPONTIN; OXIDATIVE STRESS; PROMOTER REGIONS, GENETIC; RATS; RATS, SPRAGUE-DAWLEY; TRANSFECTION;

EID: 84858304159     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2012/496540     Document Type: Article

References (41)

1. Ross R., Cellular and molecular studies of atherogenesis Atherosclerosis 1997 131 S3 S4 (Pubitemid 27306749)
2. Newby A. C., Zaltsman A. B., Molecular mechanisms in intimal hyperplasia Journal of Pathology 2000 190 3 300 309 (Pubitemid 30141376)
3. Espinola-Klein C., Rupprecht H. J., Blankenberg S., Bickel C., Kopp H., Rippin G., Victor A., Hafner G., Schlumberger W., Meyer J., Impact of infectious burden on extent and long-term prognosis of atherosclerosis Circulation 2002 105 1 15 21 (Pubitemid 34049136)
4. Albert R. E., Vanderlaan M., Burns F. J., Nishizumi M., Effect of carcinogens on chicken atherosclerosis Cancer Research 1977 37 7 2232 2235
5. Ramos K. S., Zhang Y., Sadhu D. N., Chapkin R. S., The induction of proliferative vascular smooth muscle cell phenotypes by benzo(a)pyrene is characterized by up-regulation of inositol phospholipid metabolism and c-Ha-ras gene expression Archives of Biochemistry and Biophysics 1996 332 2 213 222 (Pubitemid 26260382)
6. Ross R., The pathogenesis of atherosclerosis: a perspective for the 1990s Nature 1993 362 6423 801 809 (Pubitemid 23132154)
7. Thyberg J., Hultgardh-Nilsson A., Fibronectin and the basement membrane components laminin and collagen type IV influence the phenotypic properties of subcultured rat aortic smooth muscle cells differently Cell and Tissue Research 1994 276 2 263 271 (Pubitemid 24125474)
8. Ramos K. S., Cox L. R., Aortic endothelial and smooth muscle cell cultures Methods in Toxicology: In Vitro Biological Sytems 1993 chapter 14 New York, NY, USA Academic Press 159 168
9. Lyles G. A., Singh I., Vascular smooth muscle cells: a major source of the semicarbazide-sensitive amine oxidase of the rat aorta Journal of Pharmacy and Pharmacology 1985 37 9 637 643 (Pubitemid 15016370)
10. Partridge C. R., Williams E. S., Barhoumi R., Tadesse M. G., Johnson C. D., Lu K. P., Meininger G. A., Wilson E., Ramos K. S., Novel genomic targets in oxidant-induced vascular injury Journal of Molecular and Cellular Cardiology 2005 38 6 983 996 (Pubitemid 40725946)
11. Cox L. R., Ramos K., Allylamine-induced phenotypic modulation of aortic smooth muscle cells Journal of Experimental Pathology 1990 71 1 11 18 (Pubitemid 20147159)
12. Ramos K. S., Redox regulation of c-Ha-ras and osteopontin signaling in vascular smooth muscle cells: implications in chemical atherogenesis Annual Review of Pharmacology and Toxicology 1999 39 243 265 (Pubitemid 29222559)
13. Karin M., Ben-Neriah Y., Phosphorylation meets ubiquitination: the control of NF- B activity Annual Review of Immunology 2000 18 621 663 (Pubitemid 30365393)
14. Anrather J., Racchumi G., Iadecola C., cis-Acting element-specific transcriptional activity of differentially phosphorylated nuclear factor- B Journal of Biological Chemistry 2005 280 1 244 252 (Pubitemid 40164986)
15. Perkins N. D., Achieving transcriptional specificity with NF- B International Journal of Biochemistry and Cell Biology 1997 29 12 1433 1448
16. Perkins N. D., The Rel/NF- B family: friend and foe Trends in Biochemical Sciences 2000 25 9 434 440
17. Denhardt D. T., Noda M., O'Regan A. W., Pavlin D., Berman J. S., Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival Journal of Clinical Investigation 2001 107 9 1055 1061 (Pubitemid 32422899)
18. Bidder M., Shao J. S., Charlton-Kachigian N., Loewy A. P., Semenkovich C. F., Towler D. A., Osteopontin transcription in aortic vascular smooth muscle cells is controlled by glucose-regulated upstream stimulatory factor and activator protein-1 activities Journal of Biological Chemistry 2002 277 46 44485 44496 (Pubitemid 36157883)
19. Golledge J., McCann M., Mangan S., Lam A., Karan M., Osteoprotegerin and osteopontin are expressed at high concentrations within symptomatic carotid atherosclerosis Stroke 2004 35 7 1636 1641 (Pubitemid 38823639)
20. Ohmori R., Momiyama Y., Taniguchi H., Takahashi R., Kusuhara M., Nakamura H., Ohsuzu F., Plasma osteopontin levels are associated with the presence and extent of coronary artery disease Atherosclerosis 2003 170 2 333 337 (Pubitemid 37377807)
21. Strm., Franzén A., Wngnerud C., Knutsson A.-K., Heinegrd D., Hultgrdh-Nilsson A., Altered vascular remodeling in osteopontin-deficient atherosclerotic mice Journal of Vascular Research 2004 41 4 314 322 (Pubitemid 39370274)
22. Wilson E., Parrish A. R., Bral C. M., Williams E. S., Ramos K. S., Collagen suppresses the proliferative phenotype of allylamine-injured vascular smooth muscle cells Atherosclerosis 2002 162 2 289 297 (Pubitemid 34457934)
23. Parrish A. R., Ramos K. S., Differential processing of osteopontin characterizes the proliferative vascular smooth muscle cell phenotype induced by allylamine Journal of Cellular Biochemistry 1997 65 2 267 275 (Pubitemid 27188061)
24. Lalich J. J., Coronary artery hyalinosis in rats fed allylamine Experimental and Molecular Pathology 1969 10 1 14 26
25. Barnoya J., Glantz S. A., Cardiovascular effects of secondhand smoke: nearly as large as smoking Circulation 2005 111 20 2684 2698 (Pubitemid 40740869)
26. Kovacic P., Thurn L. A., Cardiovascular toxicity from the perspective of oxidative stress, electron transfer, and prevention by antioxidants Current Vascular Pharmacology 2005 3 2 107 117 (Pubitemid 40601581)
27. Brand K., Page S., Rogler G., Bartsch A., Brandl R., Knuechel R., Page M., Kaltschmidt C., Baeuerle P. A., Neumeier D., Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion Journal of Clinical Investigation 1996 97 7 1715 1722 (Pubitemid 26105480)
28. Bourcier T., Sukhova G., Libby P., The nuclear factor -B signaling pathway participates in dysregulation of vascular smooth muscle cells in vitro and in human atherosclerosis Journal of Biological Chemistry 1997 272 25 15817 15824 (Pubitemid 27265559)
29. Newby A. C., Molecular and cell biology of native coronary and vein-graft atherosclerosis: regulation of plaque stability and vessel-wall remodelling by growth factors and cell-extracellular matrix interactions Coronary Artery Disease 1997 8 3-4 213 224 (Pubitemid 27281086)
30. McCullagh K. A., Balian G., Collagen characterisation and cell transformation in human atherosclerosis Nature 1975 258 5530 73 75
31. Andreeva E. R., Pugach I. M., Orekhov A. N., Collagen-synthesizing cells in initial and advanced atherosclerotic lesions of human aorta Atherosclerosis 1997 130 1-2 133 142 (Pubitemid 27191033)
32. Hedin U., Bottger B. A., Forsberg E., Johansson S., Thyberg J., Diverse effects of fibronectin and laminin on phenotypic properties of cultured arterial smooth muscle cells Journal of Cell Biology 1988 107 1 307 319
33. Jones S. A., Patterson J. L., Chao J.-T., Ramos K. S., Wilson E., Modulation of cyclin dependent kinase inhibitor proteins and ERK1/2 activity in allylamine-injured vascular smooth muscle cells Journal of Cellular Biochemistry 2004 91 6 1248 1259
34. Miyamoto S., Schmitt M. J., Verma I. M., Qualitative changes in the subunit composition of B-binding complexes during murine B-cell differentiation Proceedings of the National Academy of Sciences of the United States of America 1994 91 11 5056 5060 (Pubitemid 24177791)
35. Roy J., Tran P. K., Religa P., Kazi M., Henderson B., Lundmark K., Hedin U., Fibronectin promotes cell cycle entry in smooth muscle cells in primary culture Experimental Cell Research 2002 273 2 169 177 (Pubitemid 34920667)
36. Rocha S., Martin A. M., Meek D. W., Perkins N. D., p53 represses cyclin D1 transcription through down regulation of Bcl-3 and inducing increased association of the p52 NF- B subunit with histone deacetylase 1 Molecular and Cellular Biology 2003 23 13 4713 4727 (Pubitemid 36740458)
37. Moses S., Franzén A., Lvdahl C., Hultgrdh-Nilsson A., Injury-induced osteopontin gene expression in rat arterial smooth muscle cells is dependent on mitogen-activated protein kinases ERK1/ERK2 Archives of Biochemistry and Biophysics 2001 396 1 133 137 (Pubitemid 33122012)
38. Udalova I. A., Richardson A., Denys A., Smith C., Ackerman H., Foxwell B., Kwiatkowski D., Functional consequences of a polymorphism affecting NF- B p50-p50 binding to the TNF promoter region Molecular and Cellular Biology 2000 20 24 9113 9119 (Pubitemid 32246100)
39. Tong X., Yin L., Washington R., Rosenberg D. W., Giardina C., The p50-p50 NF- B complex as a stimulus-specific repressor of gene activation Molecular and Cellular Biochemistry 2004 265 1-2 171 183 (Pubitemid 41461877)
40. Grundstrm S., Anderson P., Scheipers P., Sundstedt A., Bcl-3 and NF B p50-p50 homodimers act as transcriptional repressors in tolerant CD4 + T cells Journal of Biological Chemistry 2004 279 9 8460 8468 (Pubitemid 38294739)
41. Adams C. C., Workman J. L., Binding of disparate transcriptional activators to nucleosomal DNA is inherently cooperative Molecular and Cellular Biology 1995 15 3 1405 1421